Delivery Order SPE2DB22D3501-SPE2DB25FXK99
- Not listed
- The Defense Logistics Agency awarded a $31,614.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication. The contract, issued on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive award. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under...
- The Defense Logistics Agency awarded a delivery order valued at $5,616.51 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication. This is a firm fixed price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of May 22, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $23,711.16 for Somatuline Depot 120 mg/0.5 ml by the Defense Logistics Agency Medical Supply Chain on August 11, 2025. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 2, 2025, with performance of work occurring at the contractor's Conshohocken facility. Somatuline Depot is a specialty...
- The Defense Logistics Agency awarded a $5,616.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 90 mg/0.3 ml pharmaceutical product, with an ultimate completion date of September 29, 2025. This non-set-aside competitive award was issued on September 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 29, 2025, for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication, with a ceiling value of $5,616.51. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The Defense Logistics Agency awarded a $11,233.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 90 mg/0.3 ml pharmaceutical product on August 12, 2025, with completion expected by September 3, 2025. This competitively awarded, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will...
- The Defense Logistics Agency awarded a $3,951.86 delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with performance completed by August 13, 2025. This non-set-aside, firm fixed-price contract was awarded competitively on July 23, 2025, with performance conducted at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,422.32 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectables. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply services to support federal medical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $7,903.74 for Somatuline Depot 120 mg/0.5 ml on September 2, 2025, with completion targeted for September 23, 2025. The award is a firm fixed-price, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL pharmaceutical product. This firm fixed-price delivery order, valued at $3,951.86, represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXK99Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,233.02 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 90 mg/0.3 ml injectable medication. This firm fixed price contract, issued on September 19, 2025, with an ultimate completion date of October 10, 2025, represents a non-competitive set-aside order fulfilled by the pharmaceutical distributor at its corporate headquarters in Conshohocken, Pennsylvania. As a child delivery order, this award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical and healthcare solutions distributor serving the federal government's military and veteran healthcare systems through competitively awarded contracts with the Defense Logistics Agency. The company maintains an extensive portfolio of medical product deliveries encompassing brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for Somatuline Depot, an acromegaly and neuroendocrine tumor treatment, demonstrates the contractor's ongoing capability to fulfill critical medical supply requirements for federal healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 9/19/25 |